LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib
Clinical trial NCT01085136 · COMPLETED
Trial details
- NCT number
- NCT01085136
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2013-10-01
- Enrollment
- 1154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.